Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
CSPC Pharmaceutical makes and sells generic and branded medicines, mainly in China, for conditions like stroke, cancer, infections, and heart disease.
CSPC Pharmaceutical is one of China's biggest drugmakers, and most people outside the industry have never heard of it. That is because it mostly sells medicines you take when something has already gone wrong: drugs for the brain and nervous system, cancer treatments, antibiotics, and heart and blood-pressure pills. It sells these mostly inside China, though it also ships some products overseas.
Its best-known product is a stroke medicine called NBP, which the company has sold for years and which has long been one of its biggest money-makers. The company also has a large antibiotics business, making raw ingredients and finished doses that hospitals rely on. These are not flashy wonder drugs. They are everyday treatments used at enormous scale, and the company's skill is making them cheaply and reliably and getting them into Chinese hospitals. The interesting part is where CSPC is heading. China's government has been squeezing prices on older generic drugs to make healthcare cheaper for patients, so the company has been spending heavily on research to build a pipeline of new, patent-protected medicines. It has pushed into cancer drugs and has also built a big business making mRNA vaccines and ingredients used by other drugmakers. That shift is a bet that the future is in new drugs rather than high-volume old ones.
The company is headquartered in Shijiazhuang, an industrial city in northern China. It is a reminder that in China's pharmaceutical market, the quiet giants selling cheap, essential medicines to millions of patients can be just as important as the headline-grabbing biotech firms.
Saved answer 路 last researched 15 Nov 2026